MedTrace Logo

Opioid Effects on Cognitive Function Following Colonoscopy

NCT02267681 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 150

Last updated 2016-06-29

No results posted yet for this study

Summary

This study aims to compare the effects of fentanyl and alfentanil on postprocedural cognitive function in elective endoscopy.

150 patients will be enrolled in the study. Patients meeting eligibility criteria will be randomly allocated to three groups.

The patients in Group A will be given propofol and alfentanil. The patients in Group F will be given propofol and fentanyl. Group P is designated as the control group and the patients will be given propofol for sedation.

Awareness, vital signs and pain will be evaluated. Side effects will be recorded. Patient and endoscopist satisfaction will be evaluated.

Conditions

  • Digestive System Diseases
  • Disorientation

Interventions

DRUG

Fentanyl

Intravenous fentanyl for sedation/analgesia

DRUG

Alfentanil

Intravenous alfentanyl for sedation/analgesia

DRUG

Propofol

Intravenous propofol for sedation

Sponsors & Collaborators

  • Perihan Ekmekçi

    lead OTHER

Principal Investigators

  • Perihan Ekmekçi, MD · Ufuk University

Study Design

Allocation
RANDOMIZED
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2014-10-31
Primary Completion
2016-05-31
Completion
2016-06-30

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02267681 on ClinicalTrials.gov